MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Gender-age features of autonomic heart rhythm disturbances in Parkinson’s disease patients

    I. Solodovnikova (Odessa, Ukraine)

    Objective: To determine the gender differences and age-dependent features of autonomic heart rhythm disturbances in patients with Parkinson's disease (PD). Background: Autonomic heart rate failures…
  • 2016 International Congress

    Minimum MDS-UPDRS part III change needed to convert a Parkinson’s disease patient from the OFF to full ON state with apomorphine sublingual film (APL-130277)

    H. Shill, A. Agro, E.J. Pappert, B. Dzyngel, T. Bilbault, S. Isaacson, R. Hauser (Phoenix, AZ, USA)

    Objective: Determine the minimum MDS-UPDRS Part III improvement needed to convert a patient from the morning OFF state to a full ON with APL-130277. Background:…
  • 2016 International Congress

    Apocyanin ameliorates post-stroke movement disorder in rats: Possible role of neurochemical and inflammatory alterations

    M. Kapoor, R. Sandhir, B. Nehru (Chandigarh, India)

    Objective: To study the neuroprotective efficacy of apocynin, a NADPH oxidase inhibitor in 1) alterations of post- stroke motor behaviour, 2) alterations of various neurotransmitter…
  • 2016 International Congress

    Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6

    T. Xie, D. Appelbaum, J. Bernard, M. Padmanaban, Y. Pu, C. Gomez (Chicago, IL, USA)

    Objective: To study whether spinocerebellar ataxia type 6 (SCA6) patients have parkinsonism and striatal dopamine transporter (DAT) loss compared to gender- and age-matched healthy controls.…
  • 2016 International Congress

    Resting state functional connectivity in olfactory network in de novo Parkinson’s disease

    S. Marino, L. Bonanno, F. Caminiti, F. Corallo, V. Lo Buono, S. De Salvo, G. Di Lorenzo, P. Bramanti (Messina, Italy)

    Objective: To assess the pattern of RS functional connectivity in PD patients, related to olfactory psychometric test, to elucidate olfactory-dependent cortical-subcortical functional networks. Background: Olfactory…
  • 2016 International Congress

    Parkinson’s disease (PD) quality improvement measures (QIM) and outcomes study

    J. Martello, L. Shulman, M. Armstrong, S. Reich (Baltimore, MD, USA)

    Objective: To investigate whether adherence to PD QIMs affect patient outcomes. Background: The development of QIMs is linked to the belief that physician reimbursement should…
  • 2016 International Congress

    Research of vestibular evoked myogenic potentials (VEMP) in the diagnosis of postural instability in Parkinson’s disease

    O.A. Alenicova, S.A. Likhachev (Minsk, Belarus)

    Objective: To investigate the sacculocervical reflex of patients with PD with the assessment of changes of the parameters of VEMP depending on the severity of…
  • 2016 International Congress

    Impact of white matter hyperintensity on motor compensation in Parkinson’s disease

    J.J. Lee, Y. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Korea)

    Objective: To investigate the potential impact of white matter hyperintensity (WMH) on motor compensation in Parkinson's disease (PD). Background: WMHs, the loss of vascular integrity,…
  • 2016 International Congress

    Corpus callosum thickness and area in Parkinson’s disease

    I.O. Bledsoe, D. Merkitch, G. Stebbins, B. Bernard, J.G. Goldman (Chicago, IL, USA)

    Objective: To evaluate corpus callosum thickness and area in Parkinson's disease (PD) subjects and the relationship of these measures with cognitive impairment. Background: Many PD…
  • 2016 International Congress

    Gender differences in DLB: frequency, clinical presentation and treatment

    S. Garcia-Ptacek, M.G. Kramberger, D. Aarsland (Huddinge, Sweden)

    Objective: To describe demographic and clinical characteristics and use of cholinesterase inhibitors in women and men diagnosed with DLB. Background: DLB seems to be more…
  • « Previous Page
  • 1
  • …
  • 386
  • 387
  • 388
  • 389
  • 390
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley